Cited 0 times in Scipus Cited Count

Molecular Targeted Therapy of Head and Neck Cancer: Promising Molecular Targets of Post-Epidermal Growth Factor Receptor Era

Other Title
두경부암의 표적치료: Epidermal Growth Factor Receptor의 한계 및 이를 극복하는 새로운 표적
Chang, JW | Kim, CH
Korean journal of otorhinolaryngology-head and neck surgery, 57(9). : 575-583, 2014
Journal Title
Korean journal of otorhinolaryngology-head and neck surgery
Head and neck squamous cell carcinoma (HNSCC) affects over half a million people worldwide. Despite advances in biology and medicine, only half of the patients are alive in 5 years. The epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of HNSCC cases, and it is correlated with poor responses to therapy and worse prognosis. Multiple therapies targeting this pathway have been tested. However, only a minority of patients has showed meaningful responses to these agents and almost all who do develop acquired tumor resistance after a few months of treatment. Recently, a significant interest has focused on identifying mechanisms of acquired and de novo resistance of EGFR blockage. In addition, other inhibitors of EGFR that interfere with known molecular pathways activated in HNSCC have been studied extensively, either as single agents or in combination with other treatment modalities. Here we review some of EGFR resistance mechanisms and briefly discuss new molecular therapeutic strategies to overcome that resistance in HNSCC.

Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
Ajou Authors
김, 철호
Full Text Link
Files in This Item:


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.